Uterine Cancer

Screening, Diagnosis, and Treatment

Häftad, Engelska, 2019

AvFranco Muggia,Alessandro D. Santin,Esther Oliva

1 549 kr

Beställningsvara. Skickas inom 10-15 vardagar. Fri frakt för medlemmar vid köp för minst 249 kr.

There are more than 63,000 new cases of uterine and endometrial cancer each year in the United States, up from approximately 41,000 when the first edition of Uterine Cancer was published in 2009.

Produktinformation

Utgivningsdatum2019-01-24
Mått178 x 254 x 16 mm
Vikt554 g
FormatHäftad
SpråkEngelska
SerieCurrent Clinical Oncology
Antal sidor278
Upplaga2
FörlagSpringer Nature Switzerland AG
ISBN9783030095864

Tillhör följande kategorier

Dr. Franco Muggia is a Professor in the Department of Medicine at the Perlmutter Cancer Center at NYU Langone. His medical expertise include gynecologic cancers, breast cancer, and gynecologic oncology. Dr. Alessandro Santin is a Professor of Obstetrics, Gynecology, and Reproductive Sciences at Yale School of Medicine. He is also the Clinical Research Program Leader in the Gynecologic Oncology Program at Yale Cancer Center. Dr. Esther Oliva is a Pathologist at Massachusetts General Hospital and a Professor of Pathology at Harvard Medical School.

The Essential Epidemiology of Cancer of the Endometrium.- Endometrial Cancer: Screening, Diagnosis, and Surgical Staging.- Imaging in the Diagnosis and Treatment of Endometrial Cancer.- Uterine Cancer: Pathology.- Molecular Pathology and Cytogenetics of Endometrial Carcinoma, Carcinosarcoma, and Uterine Sarcomas.- Prognostic Factors in Uterine Cancer.- Primary Hormonal Therapy of Endometrial Cancer.- Early-Stage Endometrial Cancer: Surgery.- Early-Stage Endometrial Cancer: Radiation—Less May Be More.- Therapeutic Modalities in Early-Stage Uterine Papillary Serous Carcinomas, Carcinosarcomas, Clear-Cell and Mixed Histology Carcinomas: Treatment of Choice Is Combined Chemotherapy and Radiation.- Treatment of Advanced and Recurrent Carcinoma: Chemotherapy.- Treatment for Advanced and Recurrent Carcinoma: Combined Modalities.- Management of Uterine Sarcomas.- Future Directions and New Targets in Endometrial Cancer.